Porphyrazine optical and dual optical/MR contrast and therapeutic agents
US8540967B2 · kind B2 · utility
54Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2009 |
| Grant date | Sep 24, 2013 |
| Priority date | — |
| Expiry date | Mar 3, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Porphyrazines capable of localizing in a tumor of a mammal are disclosed. The porphyrazines are used in methods of imaging a tumor and in methods of treating tumors, either alone or in combination with a chemotherapeutic agent and/or radiation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.